NCT03177044

Brief Summary

The primary aim of the project is to investigate whether a behavioural training programme improves troublesome bowel symptoms, that people with inflammatory bowel disease continue to have, despite their disease being controlled by medication. The other aim is to determine if there are factors which influence how well the training programme works. People attending an Inflammatory Bowel Disease clinic in a tertiary hospital, with bothersome bowel symptoms despite disease control, will be asked to join the study. This involves 2 to 6 sessions with a pelvic floor trained physiotherapist over a period of 6 months with further follow up at 12 months..

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

June 1, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 6, 2017

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

April 12, 2023

Status Verified

April 1, 2023

Enrollment Period

4.2 years

First QC Date

June 1, 2017

Last Update Submit

April 11, 2023

Conditions

Keywords

Inflammatory bowel disease, pelvic floor exercise

Outcome Measures

Primary Outcomes (1)

  • Patient rating of improvement in symptoms

    Proportion of patients achieving a rating of 'moderately improved' or 'substantially improved' on a 7 point Likert scale ranging from 'substantially worse' to 'substantially improved'

    At study completion, up to 12 weeks

Secondary Outcomes (9)

  • Change in Personal assessment of Constipation Symptoms (PAC-SYM) score

    From baseline to study completion (up to 12 weeks) and at 1 year

  • Change in St Marks Faecal Incontinence Score

    From baseline to study completion (up to 12 weeks) and at 1 year

  • Change in Inflammatory Bowel disease questionnaire (IBDQ) score

    From baseline to study completion (up to 12 weeks) and at 1 year

  • Change in Short Form -36 (SF-36) score

    From baseline to study completion (up to 12 weeks) and at 1 year

  • Change in Hospital Anxiety and Depression Score (HADS)

    From baseline to study completion (up to 12 weeks) and at 1 year

  • +4 more secondary outcomes

Other Outcomes (4)

  • Change in Mayo Score

    From baseline to study completion (up to 12 weeks) and at 1 year

  • Change in Harvey Bradshaw Index

    From baseline to study completion (up to 12 weeks) and at 1 year

  • Patient rating of satisfaction

    At study completion , up to 12 weeks

  • +1 more other outcomes

Study Arms (1)

Behavioural treatment

EXPERIMENTAL

2 to 6 sessions of bowel behavioural training with a pelvic floor physiotherapist

Behavioral: Behavioural treatment

Interventions

2 to 6 sessions of behavioural training with a pelvic floor physiotherapist

Also known as: Behavioural training programme
Behavioural treatment

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Proven history of inflammatory bowel disease
  • Clinical evidence of mild, stable disease or remission
  • Mayo score ≤ 4, Harvey Bradshaw index ≤ 7
  • Bothersome lower bowel symptoms of any of the following: frequency, urgency, incontinence, difficult evacuation, constipation

You may not qualify if:

  • Significant medical or psychiatric comorbidity that in the opinion of the investigators would interfere with bowel function or adherence to the protocol
  • Clinically significant narcotic or substance abuse that in the opinion of the investigators would interfere with bowel function or adherence to the protocol
  • Recognised eating disorder
  • Non- English speaking or illiterate
  • Pregnancy
  • Previous pelvic floor physiotherapy
  • Current participant in another trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Vincent's Hospital

Fitzroy, Victoria, 3065, Australia

Location

MeSH Terms

Conditions

Inflammatory Bowel DiseasesGastrointestinal Diseases

Condition Hierarchy (Ancestors)

GastroenteritisDigestive System DiseasesIntestinal Diseases

Study Officials

  • Michael A Kamm, MBBS PhD

    St Vincent's Hospital Melbourne

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
All assessments are conducted by an assessor not providing the intervention
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prospective cohort
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 1, 2017

First Posted

June 6, 2017

Study Start

June 1, 2017

Primary Completion

July 30, 2021

Study Completion

December 31, 2021

Last Updated

April 12, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations